Olive Pharmaceuticals Private Limited
About Olive Pharmaceuticals Private Limited
Data last updated:
Olive Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 26 August 2014.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2014PTC270903. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Vivek Kumar and Rajesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at A – 252/15 G.F. Aali Vihar Badarpur, New Delhi, Delhi, India – 110076.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.66 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹51,399 (net margin -31%) and EBITDA of -₹25,083 (EBITDA margin -15.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 252/15 G.F. Aali Vihar Badarpur, New Delhi, Delhi, India – 110076
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Olive Pharmaceuticals Private Limited
The main business activity of Olive Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Olive Pharmaceuticals Private Limited FY 2017 filings available
Olive Pharmaceuticals Private Limited reported revenue of ₹1.66 Lakh (up 23% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR) of Olive Pharmaceuticals Private Limited
Revenue rose 23% in the latest year. EBITDA rose 30% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Olive Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.66 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹25,083 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹51,399 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Olive Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -15.1% | •••• | •••• |
| Net Profit Margin | -31% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Olive Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vigilant Pharmaceuticals Private Limited | ₹1.68 Lakh (FY 2024) | •••• | •••• | -61.0% | •••• | Mumbai, Maharashtra, India |
| KD Emrold Pharmaceuticals Private Limited | ₹1.67 Lakh (FY 2025) | •••• | •••• | -48.0% | •••• | Delhi, India |
| Anxoo Pharmaceuticals Private Limited | ₹1.67 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Thane, Maharashtra, India |
| Rosewell Pharmaceuticals Private Limited | ₹1.66 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbi, Maharashtra, India |
| Noracare Pharmaceuticals Private Limited | ₹1.66 Lakh (FY 2025) | •••• | •••• | 253.0% | •••• | Ranchi, Jharkhand, India |
| Olive Pharmaceuticals Private Limited this company | ₹1.66 Lakh (FY 2017) | •••• | •••• | 23.0% | •••• | New Delhi, Delhi, India |
| Dr Nik Pharmaceuticals Private Limited | ₹1.65 Lakh (FY 2025) | •••• | •••• | •••• | Nagpur, Maharashtra, India | |
| Pharmacommit Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | Kolkata, West Bengal, India |
| Oberon Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2024) | •••• | •••• | -61.0% | •••• | Thrissur, Kerala, India |
| Bravit Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Vadodara, Gujarat, India |
| Adoks Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2016) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Olive Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals Private Limited is audited by SHANDILLY & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHANDILLY & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Kumar | Additional Director | 10 Sep 2015 | 11 Years 1 Months | As last reported |
| Rajesh Kumar | Additional Director | 14 Jan 2016 | 10 Years 8 Months | As last reported |
Ownership and Shareholding of Olive Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Olive Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Olive Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Prakash Kumar ceased to be Director on 25 Jul 2018.
Credit Ratings, Litigation & Regulatory Alerts for Olive Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Olive Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Olive Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Olive Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Olive Pharmaceuticals Private Limited
Olive Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Olive Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in wholesale, within the trading industry. It was incorporated on 26 August 2014 and is registered under CIN U51397DL2014PTC270903. The company has been struck off by the Registrar of Companies and is no longer operational.
Olive Pharmaceuticals had 2 directors:
- Vivek Kumar - Additional Director
- Rajesh Kumar - Additional Director
The CIN (Corporate Identification Number) of Olive Pharmaceuticals is U51397DL2014PTC270903. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Olive Pharmaceuticals is at A – 25215 G.F. Aali Vihar Badarpur, New Delhi, Delhi, India – 110076.
Olive Pharmaceuticals was incorporated on 26 August 2014. It is registered with the Registrar of Companies, Delhi.
Olive Pharmaceuticals reported revenue of ₹1.66 Lakh for FY 2017 (up 23% YoY).
Olive Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Olive Pharmaceuticals reported a net loss of ₹51,399 (net margin -31%) and EBITDA of -₹25,083 (EBITDA margin -15.1%) for FY 2017, as per its filed financial statements.
No. Olive Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Olive Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.